Doximity Expands AI Tools in Hospitals and Focuses on Pharma Advertising

According to its fiscal second-quarter earnings results, clinical AI company Doximity is expanding its AI tools in U.S. hospitals and building an advertising business model around physician searches. More than 190 health systems have purchased Doximity's AI suite, while 16 of the top 20 pharmaceutical companies opted for its AI search advertising product.

Clinical AI company Doximity is expanding its AI tools across U.S. hospitals while building an advertising business model centered on physician searches, based on its fiscal second-quarter earnings results. The number of health systems purchasing the company's AI suite increased from 165 to over 190 in a single quarter, a figure that includes 10 of the nation's top 20 hospitals.

NewYork-Presbyterian integrated the AI tools across 10 hospitals and hundreds of locations into electronic health records. Meanwhile, UC San Diego Health was among the first institutions to adopt the patient context feature, which reviews patient records, lab results, and clinical notes to generate patient-specific responses and treatment guidance. Prompts written by physicians using this feature dropped from an average of 24 words to 12 words as the system automatically retrieves relevant information.

The shift toward clinical decision support systems also brings greater risks. Doximity announced that after testing nine AI models, it found incorrect drug dosage suggestions in at least 2.3% of responses and integrated Wolters Kluwer's UpToDate medical reference content to enhance clinical reliability. Meanwhile, the company's AI search advertising product reached eight-figure bookings, targeting the U.S. pharmaceutical companies' annual search engine market of approximately $14 billion.